Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
NSE - Delayed Quote INR

ONESOURCE SPECL PHARMA L (ONESOURCE.NS)

Compare
1,238.20
-45.40
(-3.54%)
At close: February 28 at 3:30:01 PM GMT+5:30

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Mr. Neeraj Sharma MD & Director -- -- 1972
Ms. Trisha A Company Secretary & Compliance officer -- -- --
Mr. Anurag Bhagania Chief Financial Officer -- -- 1972
Mr. Biju Mathew Chief Operating Officer -- -- --
Murari Madhab Mishra Chief Human Resources Officer -- -- --
Dr. Prateek Gupta SVP & Head of Technical Development -- -- --
Mr. Milan Doshi Senior Vice President of Global BD -- -- --
Mr. Ravi Kumar Head of Corporate Strategy & Operational Excellence -- -- --

ONESOURCE SPECL PHARMA L

Star 1, Opp IIM Bangalore
Bilekahalli Bannerghatta Road
Bengaluru, 560076
India
91 80 6784 0738 https://www.onesourcecdmo.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
525

Description

OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India and internationally. The company provides end-to-end CDMO services across various phases of preclinical and clinical development and commercial supply of biologics. It also offers drug-devices, including prefilled syringes, dial and push variable and fixed dose pen injectors, pull push fixed dose pens, and autoinjectors; sterile injectables; soft gelatin capsules; and biologics solutions for microbial and mammalian cell line biopharmaceuticals, cell and gene therapy, and RNA products. OneSource Specialty Pharma Limited was formerly known as Stelis Biopharma Limited and changed its name to OneSource Specialty Pharma Limited in February 2024. The company was incorporated in 2007 and is based in Bengaluru, India.

Corporate Governance

ONESOURCE SPECL PHARMA L’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers